Covaxin's third dose demonstrates persistence of immunity against emerging COVID variants https://ift.tt/5NhT9rV

The comprehensive study has demonstrated multiple benefits of Covaxin, such as long-term immune response, cell mediated immunity, safety of booster dose, immunogenicity against spike protein, N protein and neutralizing antibody responses against alpha, beta, delta, delta plus and omicron variants. The study has been peer-reviewed and published in Journal Nature Scientific Reports.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/8nyMjJp